Fundalysisby DARKHORSESTOCKS

Scheme

Baroda BNP Paribas Health and Wellness Fund

Holds 33 companies worth ₹473 Cr in Sept 2026.

  • Fund house

    BNPThe fund house that runs this scheme.

  • AUM

    ₹487 CrBaroda BNP Paribas Health and Wellness Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 4.0% on Aug 2026, ₹507 Cr.

  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 8.6% of this scheme's NAV.

  • Fund manager

    Rohan KordeRuns it since 1 May 2026, as the fund house dates it. With Ankeet Pandya (fund manager).

Overview(5 Oct 2026)

Fund managers2

  1. Rohan KordeFund manager · May 2026 · 22y · MMS B.Com
  2. Ankeet PandyaFund manager · Jul 2026 · 12y · MBA
  1. Sanjay ChawlaJun 2025 – Jul 2026

Key facts

Benchmark
BSE Healthcare Total Return Index
Risk
Very high
Expense
Regular 2.7% · Direct 1.47%
Exit load
10% within 1 year
Started
27 Jun 2025
Minimum
Lumpsum investment - Rs 1000

Source.Its Scheme Summary Document as of 5 Oct 2026 at AMFI.

What changed(12 changes)

Sept 2026

1 change
  1. Expense ratio
    14 SeptRegular 2.79% → 2.74%Direct 1.56% → 1.51%

Aug 2026

1 change
  1. Expense ratio
    13 AugRegular 2.77% → 2.79%Direct 1.04% → 1.56%

Jul 2026

3 changes
  1. Ankeet Pandya joined
    14 Julas fund manager
  2. Sanjay Chawla left
    14 Julran it as fund manager from Jun 2025
  3. Expense ratio
    14 JulRegular 3.09% → 2.77%Direct 1.35% → 1.04%

Source.Its filings at NSE, since Jul 2025.

Fund managers over time(Jun 2025 – now)

  1. Rohan Korde
  2. Ankeet Pandya
  3. Sanjay Chawla
MainCoSlice2026
Fig. 1.Who ran it when: each manager from the date the fund house gives, or the first document listing them where it gives none, to when they left. A slice is part of it: overseas, gold and silver, or arbitrage.

Costs(Jul 2025 – Oct 2026)

Every change to the expense ratio, newest first.
10 changesRegularDirectΔ pt
14 Sept 20262.74%1.51%0.05
13 Aug 20262.79%1.56%0.52
14 Jul 20262.77%1.04%0.31
14 Jun 20263.09%1.35%0.02
14 May 20263.07%1.33%0.43
14 Apr 20263.49%1.76%1.16
12 Jan 20262.33%0.60%0.01
14 Dec 20252.32%0.59%0.16
14 Aug 20252.28%0.43%0.01
15 Jul 20252.29%0.44%–
Direct plan, 14 Sept 2026
1.51%
Regular plan 2.74% · Exit load 10% within 1 year
Fig. 1.Total expense ratio a year, each plan's, as its Scheme Summary Documents state it, filing by filing at NSE. A change holds until the next.

Objective and risk(5 Oct 2026)

Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Risk, type and benchmark

Riskometer
Very High
At launch
Very High
Type
An open ended equity scheme investing in Pharma and Healthcare sector
Benchmark
BSE Healthcare Total Return Index
Benchmark 2
Nifty 50 TRI

Asset allocation it may hold% of NAV

  1. Equity & equity related instruments of companies in the Pharma & Healthcare and allied sector
    Allowed80–100%
  2. Equity and equity related instruments of companies other than above
    Allowed0–20%
  3. Money Market and other liquid instruments*, Gold and Silver instruments (through ETFs)
    Allowed0–20%
  4. Units of Mutual Funds as permitted by SEBI
    Allowed0–10%Holds0.0%
  5. Units issued by InvITs
    Allowed0–10%Holds0.0%

Holds in Sept 2026.97.1% equity · 2.9% debt and cash

How to invest(5 Oct 2026)

Buying

To start
Lumpsum investment - Rs 1000, then in multiples of ₹1
To add
₹1,000, then multiples of Rs1/- therefore
Most
NIL
Systematic
SIP - Daily, Weekly, Monthly, Quarterly SWP - Weekly, Monthly & Quarterly STP - Daily, Weekly, Fortnightly, Monthly & Quarterly
Minimum
SIP - 500 for daily, weekly & monthly and 1500 for quarterly SWP - Rs. 1000 for Weekly, Monthly and 1500 for quarterly STP - Rs. 1000 for daily, weekly, fortnightly, monthly and Rs. 1500 for quarterly, then sIP - Rs. 1 SWP - Rs. 1 STP - Rs. 1

Selling and switching

To redeem
Rs 1000 and multiples of Rs1/- therefor or There will be no minimum redemption criterion for Unit based redemption units
Minimum balance
NIL or NIL units
Switch minimum
Lumpsum investment - Rs 1000 or NIL units
Switch multiples
Multiples of Rs1/- therefore or NIL units
Switch most
NIL or NIL units

Scheme details(5 Oct 2026)

What it is

Category
Sectoral/Thematic Fund - Pharma and Healthcare Theme
Offer
9 Jun 2025 to 23 Jun 2025
Started
27 Jun 2025
Reopened
1 Jul 2025
Matures
NIL
Plans
Baroda BNP ParibasHealth and Wellness Fund- Regular Plan · Baroda BNP Paribas Health and Wellness Fund- DirectPlan
Face value
₹10
Listed
At present, the Units of the Scheme are not proposed to be listed on any stock exchange. However, the AMC / Trustee may at their sole discretion list the Units under the Scheme on one or more stock exchanges at a later date.

How it is run

Swing pricing
NIL
Side-pocketing
Yes
Custodian
Deutsche Bank AG
Auditor
SR Batliboi & Co LLP
Registrar
KFin Technologies Limited
SEBI code
BBNP/O/E/THE/24/12/0050